Efficacy and safety of telitacicept in primary Sj?gren's syndrome: a randomized, double-blind, placebo-controlled, phase 2 trial.

DOI:10.1093/rheumatology/kead265
作者：Dong Xu,?Jianmin Fang,?Shangzhu Zhang,?Cibo Huang,?Chenghui Huang,?Li Qin,?Xiaomei Li,?Meiqing Chen,?Xiumei Liu,?Yi Liu,?Zhijun Li,?Jiankang Hu,?Chunde Bao,?Wei Wei,?Jing Tian,?Xinwang Duan,?Xiaofeng
文献类型：期刊论文
补充材料：只需要正文